REST EZ Inc (OTC: RTEZ) is a dietary supplement company that markets a sleep aid soft gel capsule to adult consumers who experience difficulty sleeping. Revenue comes from transactional product sales through wholesalers, retail chain stores, and direct online sales at RestEz.net. The company was incorporated in Wyoming on October 17, 2016. As of March 31, 2025, 27,537,033 shares of common stock were issued and outstanding, held by 70 holders of record. Manufacturing is outsourced to an unaffiliated third-party manufacturer, Sport Energy. Direct sales are conducted by Brandon Sosa, who also serves as the sole member of the Board of Directors as of the fiscal year ended March 31, 2025. REST EZ has never declared or paid a cash dividend and retains any earnings to fund operations. The company's common stock is classified as a penny stock under the Securities Exchange Act of 1934.

Revenue model

Transactional product sales of the Rest EZ Sleep Aid Supplement soft gel capsule through wholesalers, retail chain stores, and direct online sales at RestEz.net.

Products and services

Rest EZ Sleep Aid Supplement soft gel capsule, a liquid gel capsule containing melatonin, soybean oil, gelatin, valerian root, rosehips extract, L-Theanine, L-Threonine, St. John's Wort extract, lemon balm leaf extract, niacin, lecithin, yellow beeswax, and purified water. The product is taken orally at bedtime, with a serving size of two capsules per day. Classified as a dietary supplement; not FDA pre-market approved.

Customers and end markets

Adults over 18 years of age who experience difficulty sleeping, reached through wholesalers, retail chain stores, and online direct sales.

Value-chain role

Brand owner and marketer. Manufacturing is outsourced to Sport Energy. Distribution occurs via wholesale, retail, and direct-to-consumer online channels. Point-of-sale marketing materials include advertising posters, flyers, and magnetic strips.

Geographic exposure

Nationwide wholesale and retail distribution in the United States, with stated plans to reach worldwide distributors, per the 10-K filed 2025-12-16.

Source: SEC 10-K, filed 2025-12-16

Industry: Pharmaceutical Preparations